Skip Navigation

What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital?

Blog

What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital?

What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital? By: Sandy Still, PharmD…

Blog

Why a Next-Generation Drug Diversion Solution is Vital for Hospitals.

By: Doug Zurawski, Pharm.D.   Drug diversion is any act or deviation that removes a…

Blog

The Pandemic’s Continued Strain On Labor And Other Key Takeaways From The Diversion Trends Report

Kit Check recently released its 2022 Diversion Trends Report. In the report, Kit Check analyzed…

Blog

5 Signs That You May Need Outside Help with Your Drug Diversion Program

Every hospital today is in some stage of planning, implementing and/or managing a drug diversion…

Blog

Diversion Quarterly — Q3 2020

Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly…

Blog

Doug Zurawski in Pharmacy Times – Enter AI: How Technology is Changing the Pharmaceutical Industry for the Better

Doug Zurawski, Senior Vice President of Clinical Strategy at Kit Check, was recently published in…

Blog

Nursing during COVID-19: A Chat with AJ Rivosecchi and Carol Purcell

Kit Check’s Senior Director of Clinical Strategy AJ Rivosecchi sat down (virtually) with Carol Purcell,…

Blog

Webinar Recording: Current Perspectives and Future Trends in Diversion Detection Webinar

Recently we hosted an online symposium around the topic of diversion detection. We were honored …

Blog

Kit Check Presents Groundbreaking Drug Diversion Symposium Featuring Top Industry Leaders

Continuing education webinar addresses critical components, perspectives and best practices for hospitals, pharmacists and medical …

Blog

Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis

The nation is in the grip of a tragic opioid crisis, and drugs that are …

1 of 3